MetaCap

Merck Statistics

NYSE: MRKHealth CareBiotechnology: Pharmaceutical PreparationsUSD

133.72+0.91 (+0.69%)

At close: Nov 20, 4:02 PM ET · Delayed 15 min

Merck by the numbers

Merck has a market capitalization of $329.65 billion based on 2.47B shares outstanding. Its trailing P/E ratio is 135.1, above the 8-company peer median of 30.9, and its forward P/E is 14.9. The stock trades 8.0% below its 50-day average and 3.5% above its 200-day average.

Average daily trading volume is 9.81M shares, or about $1.31 billion in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

MRK valuation vs. peer median

MRK compared with the median of 8 peer companies
MetricMRKPeer medianDifference
Market cap$329.65B$172.54B+91%
P/E (TTM)135.130.9+337%
Forward P/E14.915.3-2%
Dividend yield2.51%3.10%-19%
Avg. volume9.81M6.86M+43%

Peer median across 8 companies: NVS, AZN, ABT, NVO, PFE, ABBV, VRTX, BMY.

Valuation

Market cap
$329.65B
P/E (TTM)
135.07
Price / sales (latest FY)
5.07

Price and trading

Previous close
132.81
Open
134.33
Day range
133.11 – 137.17
52-week range
96.06 – 156.92
52-week change
+36.78%
Beta
—
Volume
15.61M

Dividends and events

Annual dividend
$3.36
Next earnings date
Oct 29, 2026

Additional statistics

Market Cap
329.65B
Pe
135.07
Forward Pe
14.92
Eps
0.99
Dividend Yield
2.63%
Dividend Rate
3.36
Week52 High
156.92
Week52 Low
96.06
Avg Volume
9.81M
Shares Outstanding
2.47B
Ma50
145.28
Ma200
129.22
Earnings Date
Oct 29, 2026
Pct From52w High
-14.78%
Pct From52w Low
39.20%

Related